TRADITIONAL ROYALTY PURCHASE AGREEMENT This TRADITIONAL ROYALTY PURCHASE AGREEMENT, dated as of April 29, 2024 (this “Agreement”), is made and entered into by and between Daré Bioscience, Inc., a Delaware corporation (the “Seller”) and XOMA (US) LLC,...Traditional Royalty Purchase Agreement • August 12th, 2024 • Dare Bioscience, Inc. • Pharmaceutical preparations • New York
SYNTHETIC ROYALTY PURCHASE AGREEMENT This SYNTHETIC ROYALTY PURCHASE AGREEMENT, dated as of April 29, 2024 (this “Agreement”), is made and entered into by and between Daré Bioscience, Inc., a Delaware corporation (the “Seller”) and XOMA (US) LLC, a...Synthetic Royalty Purchase Agreement • August 12th, 2024 • Dare Bioscience, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENTEmployment Agreement • August 12th, 2024 • Dare Bioscience, Inc. • Pharmaceutical preparations
This Amendment No. 2 to Employment Agreement (this “Amendment”) is entered into as of May 20, 2024, between Daré Bioscience, Inc. (the “Company”), and the undersigned individual who is an executive of the Company (“Executive”).
AMENDMENT 3 to GRANT AGREEMENT Investment ID INV-026060 AMENDMENT SUMMARY PAGEGrant Agreement • August 12th, 2024 • Dare Bioscience, Inc. • Pharmaceutical preparations
THIS AMENDMENT amends, and is made part of, the above-referenced Agreement and is effective as of the Amendment Date. Capitalized terms not defined in this Amendment will have the meaning provided in the Agreement. Except as modified by this Amendment, all other terms and conditions of the Agreement remain in full force and effect. In the event of a conflict between the Agreement and this Amendment, the terms of this Amendment will prevail.
